JNM Global

Global Approval Partner

분류 전체보기 2541

Indonesia BPOM, Announcement regarding New Regulations on Contaminant Limits in Cosmetics

On September 18, 2024, the Indonesian Food and Drug Authority (BPOM) announced new regulations to replace regulations on contamination limits in cosmetics established in 2019. The updated regulations regarding contamination limits in cosmetics include the following additions: The introduction of contamination limits for acrylamide and diethylene glycol regarding chemical contamination in cosmeti..

JNM Global/Cosmetic 2024.10.14

Vietnam IMDA, Introduction of Guidance for Updating Documents of Medical Device Registration Facilities

On August 16, 2024, Vietnam introduced new guidance allowing the update of specific documents related to medical device registration facilities on the IMDA website during the regulatory review process.  This guidance permits updates for two types of documents related to changes in registration facilities. 1. Updating documents related to changes in registration facility information      - When c..

Vietnam IMDA, Online Public Service System Domain Changed from DMEC to IMDA

Vietnam's Ministry of Health announced on August 30, 2024 regarding the domain change of the online public service system for medical device management. Vietnam's Ministry of Health changes the domain of the online public service system for medical device management as follows. - Domain before change (DMEC): https://dmec.moh.gov.vn- Domain after change (IMDA): https://imda.moh.gov.vn From Septem..

U.S. FDA, Voluntary Malfunction Summary Reporting (VMSR) Program Update

The FDA receives more than 2 million medical device reports (MDRs) annually related to deaths, serious injuries, and malfunctions of medica devices. Especially malfunction reports represent most of the MDRs received each year.  On August 28, 2024, the FDA announced final guidance for the Voluntary Malfunction Summary Reporting (VMSR) program for manufacturers. The VMSR program simplifies the rep..

Korea MFDS, Partial Revision on Regulation of Labeling Cosmetics Precautions for Use and Fragrance Allergens

The Ministry of Food and Drug Safety (MFDS) has strengthened the labeling obligations on containers and packaging for certain cosmetics with small amounts of contents through the update of the “Enforcement Rule of the Cosmetics Act” Accordingly, on September 24, 2024, the MFDS newly established types of cosmetics with small volumes or weights that require labeling of precautions for use, and it ..

JNM Global/Cosmetic 2024.10.07

U.S. FDA, Announcement on final guidance on De Novo request electronic submission

The De Novo classification is an FDA regulatory mechanism used for new medical devices that are anticipated to be Class I or Class II with low risk when there is no suitable predicate device to claim substantial equivalence. The FDA announced the final guidance on the electronic submission template for De Novo (FDA-2023-D-3788) on August 23, 2024. This guidance includes on the use of the electro..

Swiss Swissmedic, Open Swissdamed Database First Modules (Actors)

swissdamed is the new Swissmedic database for registering economic operators and medical devices, including in vitro diagnostic medical devices, on the Swiss market. The new medical devices platform "swissdamed" will be introduced gradually from 6 August 2024. swissdamed is being rolled out in phases. The first release of the "Actors" module enables economic operators to register online. Economi..

UK MHRA, Opens Consultation on Update to Statutory Fees

UK medical device regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) announced the launch of a consultation to seek views from interested stakeholders on proposals to update its statutory fees.  MHRA consultation on statutory fees - proposals on ongoing cost recovery are as follows. 1) Proposal 1 The MHRA proposes to increase the statutory fees shown in Annex B to ensure c..